Request Demo
Last update 29 Oct 2025
LM-2417
Last update 29 Oct 2025
Overview
Basic Info
Drug Type Bispecific antibody |
Synonyms LM 2417, LM2417 |
Target |
Action inhibitors |
Mechanism NaPi-2b inhibitors(Sodium-dependent phosphate transport protein 2B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with LM-2417NCT06682780
An Open-label, Dose-escalation, and Dose-expansion Phase I/II Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Efficacy of LM-2417 for Injection Alone or in Combination With Other Antitumor Agents in Patients With Advanced Solid Tumors
CTR20244216
一项注射用LM-2417单药或联合其它抗肿瘤药物在晚期恶性实体肿瘤患者中的安全性、耐受性、药代动力学特征以及初步疗效的开放标签、剂量递增和剂量扩展的I/II期临床研究
[Translation] An open-label, dose-escalation and dose-expansion Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of LM-2417 for injection alone or in combination with other anti-tumor drugs in patients with advanced malignant solid tumors
100 Clinical Results associated with LM-2417
Login to view more data
100 Translational Medicine associated with LM-2417
Login to view more data
100 Patents (Medical) associated with LM-2417
Login to view more data
100 Deals associated with LM-2417
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | China | 17 Sep 2025 | |
| Lung Cancer | Phase 1 | China | - | |
| Ovarian Cancer | Phase 1 | China | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free